Research
We are drawn to the difficult problems, the ones for which prevailing science does not yet have a framework to understand. Our strength is in developing new paradigms to tackle these problems and opening new avenues to transform human health
Excellence in Scientific Discovery
A commitment to scientific discovery is one of Stanford Medicine's defining strengths. In ways that cannot be anticipated, the knowledge generated by unfettered exploration yields the building blocks for tomorrow's revolutionary clinical applications.
Explore Departments:
Basic science | Clinical science
Bench-to-Bedside Research
Researchers and clinician-scientists at Stanford Medicine work across disciplines to expand the frontiers of scientific understanding while moving the most promising breakthroughs into tangible health benefits through clinical trials.
Learn about our translational research
Search clinical trials
Core Research Facilities
Interdisciplinary Collaboration
With access to the resources of Stanford University -- including the Schools of Engineering, Law, Business, Humanities & Sciences and Education -- Stanford Medicine enables close interactions between physicians and scientists, faculty and trainees, and basic science and clinical care.
Researchers found that surgical masks impede the spread of COVID-19 and that just a few, low-cost interventions increase mask-wearing compliance.
Discovery & Innovation to Improve Human Health
Faculty Research
Faculty research across the basic and clinical sciences is helping to unlock tomorrow's medical breakthroughs.
Research news
-
Sex-typical behavior of mice guided by differences in brain’s gene activity
Stanford scientists found more than 1,000 gene-activation differences between female and male mice’s brains, plus more than 600 between females in different stages of their reproductive cycle.
-
Discovery of hundreds of genes potentially associated with ALS may steer scientists toward treatments
Using machine learning, Stanford Medicine scientists and their colleagues have found hundreds of genes that could play a role in amyotrophic lateral sclerosis.
-
Antibodies in blood soon after COVID-19 onset may predict severity
A look at antibodies in patients soon after they were infected with the virus that causes COVID-19 showed key differences between those whose cases remained mild and those who later developed severe symptoms.
-
Deerfield, Stanford University create Porter Alliance for Innovative Medicines
Deerfield Management, a health care investment firm, has committed up to $130 million to support innovative translational research at Stanford.
-
Two antibodies synergize in triple whammy to pediatric cancers, study finds
Two anti-cancer antibodies have a much stronger effect against pediatric nerve-cell and bone cancers in mice than either one alone, researchers have discovered.
Stanford Medicine is leading the biomedical revolution in precision health and developing the next generation of care that is proactive, predictive and precise.
With your gift, you make an investment in leading-edge research that advances understanding and enhances life for generations to come.
